Literature DB >> 32376562

[Expression of high mobility group protein B1 in periodontal tissues and its association with hepatic lipid metabolism in diabetic rats with periodontitis].

Xinfo Pei1,2, Shu Meng1,3, Ce Gou4, Qin Du5,6.   

Abstract

OBJECTIVE: To investigate the expression of high mobility group box-1 protein (HMGB1) and its downstream products, receptor for advanced glycation end-products (RAGE) and tumor necrosis factor-α (TNF-α), in periodontal tissues of diabetic rats with periodontitis, and explore the association of HMGB1 with hepatic lipid metabolism.
METHODS: Immunohistochemical staining was used to detect the expression of HMGB1, RAGE and TNF-α in the periodontal tissues in rat models of diabetes mellitus (DM), periodontitis (CP), and diabetic periodontitis (DM + CP). The serum levels of the indicators of lipid metabolism and biochemical indexes of liver damage were detected by spectroscopy.
RESULTS: The expressions of HMGB1 and RAGE in the periodontal tissues were significantly higher in DM group than in the control group, but the expression of TNF-α showed no significant difference among the groups. In CP group, the expressions of HMGB1 and TNF-α were significantly higher than those in the control group, and the expression of RAGE was comparable with that in the control group but significantly lower than that in DM and DM+CP group. The expressions of HMGB1, RAGE and TNF-α were all significantly higher in DM+CP group than in the control group. Compared with the control rats, the rats in DM, CP, DM+CP group all showed abnormal hepatic lipid metabolism with significantly elevated serum ALT levels.
CONCLUSIONS: HMGB1 and RAGE participate in the inflammation of the periodontal tissues in diabetic rats. Diabetes leads to elevated expression of HMGB1 in the periodontal tissues. Both periodontitis and hyperglycemia contribute to liver metabolic dysfunction. HMGB1- RAGE provides clues in the study of signaling pathways underlying the mutual susceptibility of diabetes and periodontitis.

Entities:  

Keywords:  diabetes; high mobility group box-1 protein; liver; periodontitis; receptor for advanced glycation end-products

Mesh:

Substances:

Year:  2020        PMID: 32376562      PMCID: PMC7040768          DOI: 10.12122/j.issn.1673-4254.2020.01.02

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  25 in total

1.  Liver enzymes concentrations are closely related to prediabetes: findings of the Shanghai Diabetes Study II (SHDS II).

Authors:  Fei Gao; Jie Min Pan; Xu Hong Hou; Qi Chen Fang; Hui Juan Lu; Jun Ling Tang; Hui Lin Gu; Zhi Jian Pan; You Hua Yao; Wei Zhen Shen; Wei Ping Jia
Journal:  Biomed Environ Sci       Date:  2012-02       Impact factor: 3.118

2.  Expression of HMGB1 and HMGN2 in gingival tissues, GCF and PICF of periodontitis patients and peri-implantitis.

Authors:  Lin Luo; Ping Xie; Ping Gong; Xiao-hai Tang; Yi Ding; Lu-Xia Deng
Journal:  Arch Oral Biol       Date:  2011-05-12       Impact factor: 2.633

3.  Influence of periodontitis and scaling and root planing on insulin resistance and hepatic CD36 in obese rats.

Authors:  Jia Ni; Lei Chen; Sulan Zhong; Qiaoxue Chai; Lin Zhang; Dan Wang; Shaobing Li; Jincai Zhang
Journal:  J Periodontol       Date:  2018-03-30       Impact factor: 6.993

Review 4.  Effect of periodontal disease on diabetes: systematic review of epidemiologic observational evidence.

Authors:  Wenche S Borgnakke; Pekka V Ylöstalo; George W Taylor; Robert J Genco
Journal:  J Clin Periodontol       Date:  2013-04       Impact factor: 8.728

5.  The Impact of Obesity and Type 2 Diabetes on Chronic Liver Disease.

Authors:  Zobair M Younossi; Linda Henry
Journal:  Am J Gastroenterol       Date:  2019-11       Impact factor: 10.864

Review 6.  An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies.

Authors:  Domenica Musumeci; Giovanni N Roviello; Daniela Montesarchio
Journal:  Pharmacol Ther       Date:  2013-11-09       Impact factor: 12.310

7.  Noninvasive Biomarkers in Assessment of Liver Fibrosis in Patients with HBeAg Negative Chronic Hepatitis B.

Authors:  Marija Dimzova; Irena Kondova-Topuzovska; Mile Bosilkovski; Ljubomir Ivanovski; Zvonko Milenkovic; Vesna Semenakova-Cvetkovska; Nikola Orovcanec
Journal:  Open Access Maced J Med Sci       Date:  2018-06-08

8.  Remote Ischemic Preconditioning and Diazoxide Protect from Hepatic Ischemic Reperfusion Injury by Inhibiting HMGB1-Induced TLR4/MyD88/NF-κB Signaling.

Authors:  Won Uk Koh; Jiye Kim; Jooyoung Lee; Gi-Won Song; Gyu Sam Hwang; Eunyoung Tak; Jun-Gol Song
Journal:  Int J Mol Sci       Date:  2019-11-24       Impact factor: 5.923

9.  HMGB1 localization during experimental periodontitis.

Authors:  Andressa Vilas Boas Nogueira; João Antonio Chaves de Souza; Rafael Scaf de Molon; Elyne da Silva Mariano Pereira; Sabrina Garcia de Aquino; William V Giannobile; Joni Augusto Cirelli
Journal:  Mediators Inflamm       Date:  2014-02-20       Impact factor: 4.711

Review 10.  The Role of Skin and Orogenital Microbiota in Protective Immunity and Chronic Immune-Mediated Inflammatory Disease.

Authors:  Young Joon Park; Heung Kyu Lee
Journal:  Front Immunol       Date:  2018-01-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.